Investigation of the Interaction Mechanism between Salbutamol and Human Serum Albumin by Multispectroscopic and Molecular Docking

Abstract EN

Salbutamol (SBAL), a kind of short-acting beta 2-adrenergic agonist, has been mainly used to treat bronchial asthma and other allergic airway diseases clinically.

In this study, the interaction mechanism between salbutamol and human serum albumin was researched by the multispectral method and molecular docking.

The fluorescence intensity of HSA could be regularly enhanced with the increase of SBAL concentration.

Both the results of the multispectral method and molecular docking showed that SBAL could bind HSA with van der Waals force and hydrogen bonds.

The binding mechanism was further analysed by UV-Vis and synchronous fluorescence spectra.

The contents of the secondary structure of free HSA and SBAL-HSA complex were evaluated using CD spectra.